Similar articles for PMID: 31523337

Year	Number of Results
1990	1
1995	1
1996	1
1998	1
1999	1
2002	2
2003	1
2005	3
2006	2
2007	2
2008	3
2009	3
2010	3
2011	2
2012	1
2013	6
2014	6
2015	10
2016	6
2017	10
2018	5
2019	10
2020	10
2021	12
2022	6
2023	2
2024	0

1

Change in the Antimicrobial Resistance Profile of Extended-Spectrum β-Lactamase-Producing Escherichia coli.

Miyazaki M, Yamada Y, Matsuo K, Komiya Y, Uchiyama M, Nagata N, Takata T, Jimi S, Imakyure O. Miyazaki M, et al. J Clin Med Res. 2019 Sep;11(9):635-641. doi: 10.14740/jocmr3928. Epub 2019 Sep 1. J Clin Med Res. 2019. PMID: 31523337 Free PMC article.

2

[Evaluation of antibiotic treatments for urinary tract infections in the elderly, especially regarding the effect on extended spectrum β-lactamase producing (ESBL-) Escherichia coli: A comparison between meropenem and alternatives].

Yamamoto A, Yamasaki K. Yamamoto A, et al. Nihon Ronen Igakkai Zasshi. 2015;52(2):153-61. doi: 10.3143/geriatrics.52.153. Nihon Ronen Igakkai Zasshi. 2015. PMID: 25994987 Free article. Japanese.

3

Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.

Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ. Liu HY, et al. J Microbiol Immunol Infect. 2011 Oct;44(5):364-8. doi: 10.1016/j.jmii.2010.08.012. Epub 2011 Jan 20. J Microbiol Immunol Infect. 2011. PMID: 21524974 Free article.

4

Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates.

Bonkat G, Müller G, Braissant O, Frei R, Tschudin-Suter S, Rieken M, Wyler S, Gasser TC, Bachmann A, Widmer AF. Bonkat G, et al. World J Urol. 2013 Dec;31(6):1427-32. doi: 10.1007/s00345-013-1031-5. Epub 2013 Jan 29. World J Urol. 2013. PMID: 23358791

5

Phenotypic Characterization and Antibiograms of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolated at the Human-Animal-Environment Interface Using a One Health Approach Among Households in Wakiso District, Uganda.

Muleme J, Kankya C, Munyeme M, Musoke D, Ssempebwa JC, Isunju JB, Wambi R, Balugaba BE, Sekulima T, Mugambe RK, Cadmus S, Kajumbula HM. Muleme J, et al. Infect Drug Resist. 2023 Apr 14;16:2203-2216. doi: 10.2147/IDR.S398951. eCollection 2023. Infect Drug Resist. 2023. PMID: 37081947 Free PMC article.

6

Prevalence of Cefotaxime-Resistant Escherichia coli Isolates from Healthy Cattle and Sheep in Northern Spain: Phenotypic and Genome-Based Characterization of Antimicrobial Susceptibility.

Tello M, Ocejo M, Oporto B, Hurtado A. Tello M, et al. Appl Environ Microbiol. 2020 Jul 20;86(15):e00742-20. doi: 10.1128/AEM.00742-20. Print 2020 Jul 20. Appl Environ Microbiol. 2020. PMID: 32471914 Free PMC article.

7

Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli.

Abe Y, Inan-Erdogan I, Fukuchi K, Wakabayashi H, Ogawa Y, Hibino S, Sakurai S, Matsuhashi K, Watanabe Y, Hashimoto K, Ugajin K, Itabashi K. Abe Y, et al. J Infect Chemother. 2017 Aug;23(8):517-522. doi: 10.1016/j.jiac.2017.04.006. Epub 2017 May 18. J Infect Chemother. 2017. PMID: 28528936

8

Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.

Komatsu Y, Kasahara K, Inoue T, Lee ST, Muratani T, Yano H, Kirita T, Mikasa K. Komatsu Y, et al. PLoS One. 2018 Aug 29;13(8):e0202276. doi: 10.1371/journal.pone.0202276. eCollection 2018. PLoS One. 2018. PMID: 30157275 Free PMC article.

9

Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.

Cho YH, Jung SI, Chung HS, Yu HS, Hwang EC, Kim SO, Kang TW, Kwon DD, Park K. Cho YH, et al. Int Urol Nephrol. 2015 Jul;47(7):1059-66. doi: 10.1007/s11255-015-1018-9. Epub 2015 May 31. Int Urol Nephrol. 2015. PMID: 26026972

10

In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan.

Liao CH, Sheng WH, Wang JT, Sun HY, Wang HK, Hsueh PR, Chen YC, Chang SC. Liao CH, et al. J Microbiol Immunol Infect. 2006 Feb;39(1):59-66. J Microbiol Immunol Infect. 2006. PMID: 16440125

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year